0001415889-19-000009.txt : 20190102
0001415889-19-000009.hdr.sgml : 20190102
20190102175532
ACCESSION NUMBER: 0001415889-19-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181228
FILED AS OF DATE: 20190102
DATE AS OF CHANGE: 20190102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Riddell Alastair
CENTRAL INDEX KEY: 0001681349
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37853
FILM NUMBER: 19502926
MAIL ADDRESS:
STREET 1: C/OAZURRX BIOPHARMA,INC.760 PARKSIDE AVE
STREET 2: DOWNSTATE BIOTECHNOLOGY INCUBATOR,STE217
CITY: BROOKLY
STATE: NY
ZIP: 11226
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AzurRx BioPharma, Inc.
CENTRAL INDEX KEY: 0001604191
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 760 PARKSIDE AVENUE
STREET 2: SUITE 304
CITY: BROOKLYN
STATE: NY
ZIP: 11226
BUSINESS PHONE: 646-699-7855
MAIL ADDRESS:
STREET 1: 760 PARKSIDE AVENUE
STREET 2: SUITE 304
CITY: BROOKLYN
STATE: NY
ZIP: 11226
FORMER COMPANY:
FORMER CONFORMED NAME: BioPharma d'Azur, Inc.
DATE OF NAME CHANGE: 20140331
4
1
form4-01022019_020116.xml
X0306
4
2018-12-28
0001604191
AzurRx BioPharma, Inc.
AZRX
0001681349
Riddell Alastair
SUITE 304
BROOKLYN
NY
11226
true
false
false
false
Common Stock
2018-12-28
4
A
0
7500
1.29
A
70000
D
Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2018.
/s/ Maged Shenouda, Attorney-in-Fact
2019-01-02